ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LOVE Cannara Biotech Inc

0.73
0.03 (4.29%)
Last Updated: 15:05:32
Delayed by 15 minutes
Share Name Share Symbol Market Type
Cannara Biotech Inc TSXV:LOVE TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.03 4.29% 0.73 0.73 0.75 0.73 0.71 0.71 10,000 15:05:32

Cannara Biotech Inc. To Participate At Canaccord Genuity's 7th Annual Global Cannabis Conference

11/05/2023 1:00pm

PR Newswire (Canada)


Cannara Biotech (TSXV:LOVE)
Historical Stock Chart


From Nov 2022 to Nov 2024

Click Here for more Cannara Biotech Charts.

MONTREAL, May 11, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices  with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its upcoming participation at Canaccord Genuity's 7th annual global cannabis conference.  This one-day event will feature company presentations and one-on-one meetings with senior management teams representing the most reputable and recognizable names in the thriving cannabis industry. 

Cannara Biotech Inc. Logo (CNW Group/Cannara Biotech Inc.)

Nicholas Sosiak, Chief Financial Officer of Cannara will give a presentation outlining Cannara's brief history, its current state of operations and the opportunity ahead for existing and potential new shareholders on Thursday May 18th at 9:00 am ET.  For those interested in listening to the presentation, you may register for the event here:  https://wsw.com/webcast/canaccord88/love.v/2788332. Investors that are unable to attend the live presentation will have the opportunity to watch a recording on the investor page of the company website cannara.ca.

Nicholas Sosiak, Chief Financial Officer of Cannara commented, "We are excited to have been selected to present at one of the premier cannabis conferences in the industry.  Cannara has achieved so much in its brief existence, the management team and I are very proud of our accomplishments. I look forward to showcasing the Cannara name to all of the reputable investors taking part in this tremendous event".

About Cannara Biotech Inc. 

Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Québec and Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 120,000kg of potential annualized cultivation output. Leveraging Québec's low electricity costs, Cannara's facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca. 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cannara-biotech-inc-to-participate-at-canaccord-genuitys-7th-annual-global-cannabis-conference-301811548.html

SOURCE Cannara Biotech Inc.

Copyright 2023 Canada NewsWire

1 Year Cannara Biotech Chart

1 Year Cannara Biotech Chart

1 Month Cannara Biotech Chart

1 Month Cannara Biotech Chart